New study examines Igalmi's effects after repeated use for agitation
NCT ID NCT06041646
First seen Jan 04, 2026 · Last updated May 23, 2026 · Updated 27 times
Summary
This study looked at how the body builds tolerance to Igalmi (a fast-acting medicine for agitation) and what happens when it's stopped. It involved 29 adults with schizophrenia or bipolar disorder who had frequent agitation. Researchers measured changes in agitation levels and watched for side effects during a 3-day follow-up period.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SCHIZOPHRENIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
BioXcel Clinical Research Site
Little Rock, Arkansas, 72211, United States
-
BioXcel Clinical Research Site
Rogers, Arkansas, 72758, United States
Conditions
Explore the condition pages connected to this study.